Monday, 27 June 2016

Rise in Geriatric Population will Fuel Expansion of Global Nurse Call Systems Market at 13.90% CAGR

A new Transparency Market Research report states that the global nurse call systems market stood at US$0.6 bn in 2013 and is anticipated to reach US$1.6 bn by 2020. It is expected to expand at a CAGR of 13.90% from 2014 to 2020. The title of the report is “Nurse Call Systems Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2014 - 2020.”

Get a Free Sample Report:

According to the report, factors such as the rising aging population and the growing need for responsive and efficient healthcare communication are amongst the major factors propelling the growth of the market for nurse call systems. In addition, the globally rising budget allocation in healthcare for elderly people is also a prime factor augmenting the growth of the market. In addition, the rise of the Internet of Things (IoT) within healthcare infrastructure has emerged as a key opportunity in the market. On the other hand, government regulations on distribution and manufacturing of nurse call systems are amongst the major factors impeding the growth of the market.

In terms of equipment type, the market is segmented into nurse call intercoms, nurse call buttons, nurse call integrated communication systems, and nurse call mobile systems. Amongst these, the segment of nurse call integrated communication systems led the market in 2013. On the other hand, the segment of nurse call mobile systems is predicted to expand at the highest growth rate in the forecast horizon owing to the rising demand for mobile solutions.

On the basis of communication technology, the report segments the market into wireless communication equipment and wired communication equipment. Amongst these, wired nurse call communication equipment dominated the market for nurse call systems in 2013. On the other hand, the demand for wireless nurse call communication equipment is poised to rise in the forecast horizon owing to the rising demand for flexibility and mobility in communication.

On the basis of end use, the nurse call systems market is segmented into OPD clinics, hospitals, ambulatory services, and assisted living centers. Amongst these, in 2013, the segment of hospitals constituted a share of approximately 74% in the market on the basis of revenue. On the other hand, factors such as the requirement for effective communication systems and patient safety will raise the demand for nurse call systems within the segment of assisted living centers in the forecast horizon.

Geographically, the market is segmented into Europe, North America, Asia Pacific, and Rest of the World (RoW). Amongst these, in 2013, North America held the largest share in the market on the basis of revenue. This is due to the rising adoption of nurse call systems within this region in numerous healthcare settings. Europe trailed North America and stood as the second largest market for nurse call systems on the basis of revenue in the same year. However, the market for nurse call systems is poised to experience sluggish growth in this region in the coming years owing to slow economic growth.

The chief players dominant in the market are Rauland-Borg Corporation, Stanley Healthcare, Hill-Rom Holdings, Inc., Tyco SimplexGrinnell, Ascom Holding AG, Cornell Communications, Inc., Azure Healthcare Limited, Jeron Electronic Systems, Inc., and Vigil Health Solutions, Inc., among others.

Full Research Report on Global Nurse Call Systems Market:

Wednesday, 22 June 2016

Disruptive Behavior Disorders Market Growth Drivers 2023

Transparency Market Research provides a thorough analysis of the global disruptive behavior disorders market through its new research report. The report, titled “Disruptive Behavior Disorders Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 – 2023,” assesses the factors driving the overall market and the ones restraining it. The researchers have used a SWOT analysis to highlight the strengths, weaknesses, opportunities, and threats impacting the segments of the overall market. Additionally, the document also includes a trajectory of the global disruptive behavior disorders market by analyzing several journals, new articles, and research papers.

Disruptive behavior disorders are characterized by adamant and unfriendly behavior, which becomes an impediment to the normal functioning of the individual. Persons suffering from these disorders exhibit temper tantrums, physical aggression, excessive disagreement, depression, poor attention span, and other symptoms that borderline resistance towards regular activities and people. Oppositional defiant disorder (ODD) and conduct disorder (CD) are the two main branches of disruptive behavior disorders, which show prominent abnormal social skill sets and an inability to function in regular circumstances. Undiagnosed disruptive behavior disorders can intensify symptoms, posing as a serious harm to the patient’s life and to those around them.

The global disruptive behavior disorders market has been assessed on the basis of therapeutics and geography. The therapeutics segment is further divided into target molecules, administration, and mechanism of action and safety of the drugs. SPN-812, SUVN-502, AZ-5213, and ORADUR-ADHD are some of the drugs under investigation in the overall market. Geographically, this market is segmented into Asia Pacific, North America, Europe, and Rest of the World.

The global disruptive behavior disorders market is being driven by the rise in the number of comorbid disorders, which can be exceptionally dangerous, if untreated. Furthermore, the increasing investments made by pharmaceutical companies to develop effective drugs and therapeutics are also expected to propel this market in the coming years. However, the poor rate of diagnosis and the improper approaches towards treatments are likely to restrain the growth of this market in the coming years.

Some of the key players in the global disruptive disorders market are Eli Lilly and Co., Pfizer, Inc., Johnson & Johnson, DURECT Corporation, Bionomics Ltd., and Chelsea Therapeutics, Inc. The research report profiles these players to provide the competitive landscape of the global market and explain the nature of expansion styles used by these players to gain a competitive edge. Furthermore, the research report also evaluates the financial overview, research and development strategies, business and marketing strategies, and strategic mergers and acquisitions of these companies for the coming few years.

Full Research Report on Global Disruptive Behavior Disorders Market:

Tuesday, 14 June 2016

3D Bioprinting Market Demand in Medical and Healthcare Sector

A new study by Transparency Market Research (TMR), titled “3D Bioprinting Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2016 - 2024,” states that the increasing application of 3D bioprinting technology in the medical and healthcare sectors across the world is the key driver of the worldwide market.

Apart from this, the increasing lifespan of individuals, the rising prevalence of chronic illnesses, the growing demand for tissue and organ transplants, the integration of information technology into the medical and healthcare sector, dearth of organ donors, advancements in 3D printing technology, and the augmenting base of the geriatric population are also driving the worldwide market for 3D bioprinting significantly, states the research study.

The report has also discussed the prospects of the global 3D bioprinting market at length. As per the study, the increasing requirement of regenerated tissues, organs, implants, and prosthetics are likely to present a lucrative opportunity for market players during the forecast period. In addition to this, the emergence of 3D bioprinted pills is projected to open new avenues for them in the coming years. The augmenting need for customized medicines and the rapid rise in the production of biodrugs are also anticipated to drive the market in the near future.

According to the report, the global market for 3D bioprinting is spread across Asia Pacific, North America, Europe, and the Rest of the World. North America leads the worldwide market in terms of revenue. The presence of an advanced medical and healthcare infrastructure, a large pool of chronically ill patients, and high spending power of people in this region is boosting the North America 3D bioprinting market significantly.

Analysts predict this regional market to retain its dominance during the forecast period, owing to continual research activities in the area of 3D printing. However, Asia Pacific is likely to surface as a strong contender for leadership in the global market for 3D bioprinting in the coming years. 

The rapid rise in the adoption advanced technologies, advancements in healthcare IT, favorable government initiatives, increasing foreign investments, and the growing awareness regarding 3D bioprinting technology are anticipated to propel the Asia Pacific 3D bioprinting market over the forecast period, states the report.

The research report has also analyzed the profiles of major companies operating in the global 3D bioprinting market and determined the current market hierarchy. Oceanz, Organovo Holding Inc., Luxexcel Group BV, TeVido BioDevices, Stratasys Ltd., Voxeljet, Solidscape, Aspect Biosystems, Materialise NV, Bio3D Technologies Pte Ltd., Cyfuse Biomedical, 3Dynamics Systems, BioBots, and Envision TEC are some of the key market players mentioned in this study.